Delivery Order SPE2DB20D1109-SPE2DB24FN30H
- Not listed
- This federal contract award, with a ceiling value of $5,401.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bridion 200mg/2ml vials, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bridion 500 mg/5 ml vials, a pharmaceutical product, with a ceiling value of $9,980.81 and a completion date of December 7, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $3,226.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bridion 200 mg/2 ml vials, a pharmaceutical product, to support U.S. government medical needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Bridion 500 mg/5 ml vials. The $13,756.62 firm-fixed-price delivery order contract has a completion date of November 20, 2023. The award is not designated under any set-aside program. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,408.00, is for the delivery of Bridion 200 mg/2 ml vials, a pharmaceutical product. This is a delivery order under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The contract is a firm-fixed-price arrangement and does...
- This federal contract award, valued at $33,539.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of Bridion 500 mg/5 ml vials, a specialty medication used for medical care. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as...
- This federal contract award is a delivery order valued at $35,339.70 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Bridion 200 mg/2 ml vial 2 ml, a pharmaceutical product. The award has an ultimate completion date of February 5, 2024 and is a Firm Fixed Price contract. The contract is not designated with a set-aside, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY1DH, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Bridion 500 mg/5 ml vials, a pharmaceutical product, with a ceiling value of $20,768.52 and a completion date of February 22, 2024. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime...
- This federal contract award, valued at $30,454.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Bridion 200 mg/2 ml vials, a pharmaceutical product, to support U.S. government healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $89,099.58, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN30HDelivery Order
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FN30H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Bridion 200 mg/2 ml vials, a pharmaceutical product, with a ceiling value of $3,369.78 and an ultimate completion date of December 22, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/21/23 |